GMP Pilot Plant Overview for Drug Manufacturing

This document is a guide detailing the GMP Pilot Plant at MUNI PHARM, which plays a critical role in the research and development of innovative and generic drugs. The facility is designed for small-batch drug manufacturing under Good Manufacturing Practice (GMP) standards, focusing on the development and production of liquid, semi-solid, and solid drug forms. It includes dedicated areas for the production of various drug forms and is equipped with Quality Control (QC) laboratories for testing and stability evaluation. The document outlines the operational capabilities of the facility, including various production operations such as milling, granulation, and sterilization, along with the equipment used in these processes. Additionally, it discusses the potential collaborations with researchers and companies, emphasizing the facility's contribution to applied research and its commercial potential in drug evaluation. The GMP Pilot Plant aims to bridge the gap between research and industrial application, enhancing the development of drug formulations.